Table 3. MTHFR mRNA expression by the genotypes of SNPs, using data from the HapMapa.
Population | C667T (rs1801133) | A1298C (rs1801131) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
genotypes | No. | Mean ± SD | Pb | Ptrendc | genotypes | No. | Mean ± SD | Pb | Ptrendc | |
CEU | CC | 48 | 6.14 ± 0.10 | 0.904 | AA | 41 | 6.12 ± 0.09 | 0.139 | ||
CT | 37 | 6.14 ± 0.09 | 0.924 | AC | 36 | 6.15 ± 0.10 | 0.069 | |||
TT | 5 | 6.12 ± 0.09 | 0.685 | CC | 13 | 6.16 ± 0.09 | 0.163 | |||
Dominant | 42 | 6.14 ± 0.09 | 0.983 | Dominant | 49 | 6.15 ± 0.09 | 0.046 | |||
YRId | CC | 70 | 6.20 ± 0.08 | 0.329 | AA | 71 | 6.20 ± 0.07 | 0.197 | ||
CT | 19 | 6.19 ± 0.06 | 0.651 | AC | 17 | 6.19 ± 0.09 | 0.504 | |||
TT | 1 | 6.09 | 0.171 | CC | 1 | 6.07 | 0.074 | |||
Dominant | 20 | 6.19 ± 0.06 | 0.470 | Dominant | 18 | 6.18 ± 0.09 | 0.317 | |||
Asiand | CC | 30 | 6.18 ± 0.08 | 0.116 | AA | 59 | 6.22 ± 0.10 | 0.074 | ||
CT | 40 | 6.21 ± 0.09 | 0.120 | AC | 28 | 6.17 ± 0.09 | 0.024 | |||
TT | 19 | 6.23 ± 0.11 | 0.052 | CC | 3 | 6.20 ± 0.06 | 0.814 | |||
Dominant | 59 | 6.22 ± 0.10 | 0.057 | Dominant | 31 | 6.17 ± 0.08 | 0.028 | |||
Alld | CC | 148 | 6.17 ± 0.09 | 0.360 | AA | 171 | 6.19 ± 0.09 | 0.186 | ||
CT | 96 | 6.18 ± 0.09 | 0.732 | AC | 81 | 6.17 ± 0.09 | 0.107 | |||
TT | 25 | 6.20 ± 0.12 | 0.156 | CC | 17 | 6.16 ± 0.09 | 0.261 | |||
Dominant | 121 | 6.18 ± 0.10 | 0.422 | Dominant | 98 | 6.16 ± 0.09 | 0.069 |
aGenotyping data and mRNA expression levels for MTHFR by genotypes were obtained from the HapMap phase II release 23 data from EBV-transformed lymphoblastoid cell lines from 270 individuals.
bTwo-side Student's t test within the stratum.
cP values for the trend test of MTHFR mRNA expression among 3 genotypes for each SNP from a general linear model.
dThere were missing data because genotyping data were not available.